Enalapril, irbesartan, and angiotensin-(1-7) prevent atrial tachycardia-induced ionic remodeling

International Journal of Cardiology

Volumn 146, Issue 3, 2011, Pages 364-370

  Liu, Enzhao ^a   Xu, Zhao ^a   Li, Jian ^a   Yang, Shengrong ^a   Yang, Wansong ^a   Li, Guangping ^a  

^a SECOND HOSPITAL OF TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiotensin (1 7); Atrial fibrillation; Ca2+ channel; K+ channel; Remodeling

Indexed keywords

ANGIOTENSIN[1-7]; ENALAPRIL; IRBESARTAN; MESSENGER RNA; POTASSIUM CHANNEL;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL DOG; FEMALE; GENE EXPRESSION; HEART ATRIUM PACING; HEART MUSCLE CELL; HEMODYNAMICS; ION CURRENT; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPRAVENTRICULAR TACHYCARDIA;

ACTION POTENTIALS; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINS; ANIMALS; ATRIAL FIBRILLATION; BIPHENYL COMPOUNDS; DOGS; ENALAPRIL; FEMALE; HEART ATRIA; ION CHANNELS; MALE; TACHYCARDIA; TETRAZOLES;

EID: 78951484402     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.07.015     Document Type: Article

References (41)

1. M.C. Wijffels, C.J. Kirchhof, R. Dorland, and M.A. Allessie Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
2. S. Nattel, A. Shiroshita-Takeshita, S. Cardin, and P. Pelletier Mechanisms of atrial remodelling and clinical relevance Curr Opin Cardiol 20 2005 21 25
3. C.T. Tsai, L.P. Lai, and J.L. Lin Renin-angiotensin system gene polymorphisms and atrial fibrillation Circulation 109 2004 1640 1646
4. J.S. Healey, C.A. Morillo, and S.J. Connolly Role of the renin-angiotensin-aldosterone system in atrial fibrillation and cardiac remodeling Curr Opin Cardiol 20 2005 31 37
5. H. Nakashima, K. Kumagai, H. Urata, N. Gondo, M. Ideishi, and K. Arakawa Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation Circulation 101 2000 2612 2617
6. +-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling Cardiovasc Res 54 2002 438 446
7. B.J. Brundel, I.C. van Gelder, and R.H. Henning Gene expression of proteins influencing the calcium homeostasis in patients with persistent and paroxysmal atrial fibrillation Cardiovasc Res 42 1999 443 454
8. J.B. Grammer, R.F. Bosch, V. Kühlkamp, and L. Seipel Molecular remodeling of Kv4.3 potassium channels in human atrial fibrillation J Cardiovasc Electrophysiol 11 2000 626 633
9. A.J. Workman, K.A. Kane, and A.C. Rankin Cellular bases for human atrial fibrillation Heart Rhythm 5 2008 S1 S6
10. K. Kumagai, H. Nakashima, H. Urata, N. Gondo, K. Arakawa, and K. Saku Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation J Am Coll Cardiol 41 2003 2197 2204
11. C.M. Ferrario Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation Hypertension 47 2006 515 521
12. M. Donoghue, F. Hsieh, and E. Baronas A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9 Circ Res 87 2000 E1 9
13. T.L. Reudelhuber A place in our hearts for the lowly angiotensin 1-7 peptide? Hypertension 47 2006 811 815
14. J.L. Grobe, A.P. Mecca, and M. Lingis Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7) Am J Physiol Heart Circ Physiol 292 2007 H736 H742
15. C.A. Morillo, G.J. Klein, D.L. Jones, and C.M. Guiraudon Chronic rapid atrial pacing: structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation Circulation 91 1995 1588 1595
16. L. Yue, J. Feng, G.R. Li, and S. Nattel Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods Am J Physiol 270 1996 H2157 H2168
17. D. Li, P. Melnyk, and J. Feng Effects of experimental heart failure on atrial cellular and ionic electrophysiology Circulation 101 2000 2631 2638
18. S. Nattel, and D. Li Ionic remodeling in the heart: pathophysiological significance and new therapeutic opportunities for atrial fibrillation Circ Res 87 2000 440 447
19. H. Nakashima, and K. Kumagai Reverse-remodeling effects of angiotensin II type 1 receptor blocker in a canine atrial fibrillation model Circ J 71 2007 1977 1982
20. L. Yue, J. Feng, R. Gaspo, G. Li, Z. Wang, and S. Nattel Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation Circ Res 81 1997 512 525
21. L. Yue, P. Melnyk, R. Gaspo, Z. Wang, and S. Nattel Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation Circ Res 84 1999 776 784
22. R. Gaspo, H. Sun, and S. Fareh Dihydropyridine and beta adrenergic receptor binding in dogs with tachycardia-induced atrial fibrillation Cardiovasc Res 42 1999 434 442
23. + current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation Circ Res 80 1997 772 781
24. R.F. Bosch, X. Zeng, J.B. Grammer, K. Popovic, C. Mewis, and V. Kuhlkamp Ionic mechanisms of electrical remodeling in human atrial fibrillation Cardiovasc Res 44 1999 121 131
25. 2+ currents and human atrial fibrillation Circ Res 85 1999 428 436
26. K1 in action potential shortening associated with atrial fibrillation in humans Cardiovasc Res 66 2005 493 502
27. A.J. Workman, K.A. Kane, and A.C. Rankin The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation Cardiovasc Res 52 2001 226 235
28. A. Goette, T. Staack, and C. Rocken Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation J Am Coll Cardiol 35 2000 1669 1677
29. R. Willems, K.R. Sipido, P. Holemans, H. Ector, F. Van de Werf, and H. Heidbuchel Different patterns of angiotensin II and atrial natriuretic peptide secretion in a sheep model of atrial fibrillation J Cardiovasc Electrophysiol 12 2001 1387 1392
30. J.R. Ehrlich, S.H. Hohnloser, and S. Nattel Role of angiotensin system and effects of its inhibition in atrial fibrillation: clinical and experimental evidence Eur Heart J 27 2006 512 518
31. J.S. Healey, A. Baranchuk, and E. Crystal Prevention of atrial fibrillation with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers: a meta-analysis J Am Coll Cardiol 45 2005 1832 1839
32. A.H. Madrid, M.G. Bueno, and J.M. Rebollo Use of irbesartan to maintain sinus rhythm in patients with long-lasting persistent atrial fibrillation. A prospective and randomized study Circulation 106 2002 331 336
33. R.A. Santos, and A.P. Almeida Angiotensin-(1-7): cardioprotective effect in myocardial ischemia/reperfusion Hypertension 38 2001 665 668
34. A.J. Ferreira, R.A. Santos, and A.P. Almeida Angiotensin-(1-7) improves the post-ischemic function in isolated perfused rat hearts Braz J Med Biol Res 35 2002 1083 1090
35. M.F. Dias-Peixoto, R.A. Santos, and E.R. Gomes Molecular mechanisms involved in the angiotensin-(1-7)/Mas signaling pathway in cardiomyocytes Hypertension 52 2008 542 548
36. C. Schindler, K.B. Brosnihan, and C.M. Ferrario Comparison of inhibitory effects of irbesartan and atorvastatin treatment on the renin angiotensin system (RAS) in veins: a randomized double-blind crossover trial in healthy subjects J Clin Pharmacol 47 2007 112 120
37. D.B. Averill, Y. Ishiyama, M.C. Chappell, and C.M. Ferrario Cardiac angiotensin-(1-7) in ischemic cardiomyopathy Circulation 108 2003 2141 2146
38. Y. Ishiyama, P.E. Gallagher, D.B. Averill, E.A. Tallant, K.B. Brosnihan, and C.M. Ferrario Upregulation of angiotensin converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors Hypertension 43 2004 970 976
39. R.A. Santos, J.M. Brum, K.B. Brosnihan, and C.M. Ferrario The renin-angiotensin system during acute myocardial ischemia in dogs Hypertension 15 1990 I121 I127
40. W.C. De Mello Angiotensin (1-7) re-establishes impulse conduction in cardiac muscle during ischaemia-reperfusion J Renin-Angiotensin-Aldosterone Syst 5 2004 203 208
41. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150